Document:

Form of 2006 Convertible Bridge Note, dated as of October 2006

 EXHIBIT 4.32 
 NEITHER THIS NOTE NOR ANY OF THE SECURITIES ISSUABLE UPON CONVERSION HEREOF HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR ANY STATE SECURITIES LAWS AND MAY NOT BE OFFERED FOR SALE,
SOLD OR OTHERWISE TRANSFERRED UNLESS THERE IS A REGISTRATION STATEMENT UNDER THE SECURITIES ACT AND OTHER APPLICABLE SECURITIES LAWS IN EFFECT COVERING THIS NOTE OR SUCH SECURITIES, AS THE CASE MAY BE, OR THERE IS AVAILABLE AN EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS THE AVAILABILITY OF WHICH MUST BE ESTABLISHED TO THE REASONABLE SATISFACTION OF THE MAKER HEREOF. 
 2006 CONVERTIBLE BRIDGE NOTE 
  

			
	 $                    
	 	October     , 2006
		 	(the “Original Issue Date”)

 FOR VALUE RECEIVED, Synova Healthcare Group, Inc., a Nevada corporation (the
“Maker”), hereby promises to pay to the order of                     , or his registered successors or assigns (the
“Payee”), in lawful money of the United States of America, the principal sum of
                                        
                 ($                ), together with interest on the outstanding
principal amount under this 2006 Convertible Promissory Note (this “Note”). 
 Interest on this Note shall be due and
payable monthly in cash starting one month from the date hereof, until the earlier of the Maturity Date or the Advance Date at an annual rate of twelve percent (12%) per annum, computed on the basis of the actual number of days elapsed and a
365-day year. Upon the earlier of an Event of Default, the Maturity Date or the Advance Date, interest on this Note shall accrue until this Note is paid in full, at an annual rate of fifteen percent (15%) per annum, or if lower, the highest
rate permitted by applicable law, computed on the basis of the actual number of days elapsed and a 365-day year. 
 Interest due under this
Note shall be due and payable until the date that all principal indebtedness and interest evidenced by this Note is repaid in cash in full. 
 This Note is one of a series of notes of the Maker designated as “2006 Convertible Bridge Notes” (collectively, the “2006 Bridge Notes”). The Maker may issue 2006 Bridge Notes in an original aggregate principal
amount of up to $2,000,000. 
 1. Defined Terms. For purposes of this Note, the following terms shall have the following meanings: 
 “Additional Shares of Common Stock” means all shares of Common Stock issued (or deemed to be issued as a result of any determination of
shares issued on a fully-diluted basis) by the Maker after the Original Issue Date, other than shares of Common Stock issued or issuable 

 
(i) to officers, directors, employees, strategic business partners of, or consultants to, the Maker pursuant to stock option or stock purchase plans or
agreements on terms approved by the Compensation Committee of the Board of Directors or the Board of Directors; or (ii) for which adjustment of the Conversion Price is made pursuant to Section 3 of this Note. 
 “Advance Date” means the first date on which funds are advanced to Maker or its Affiliate pursuant to a Subsequent Offering. 

“Affiliate” shall have the meaning ascribed to that term in Rule 12b-2 under the Securities Exchange Act of 1934, as amended, and the
rules and regulations of the Commission promulgated thereunder. 
 “Common Stock” means the common stock of the Maker, $.001
par value per share, as constituted on the Original Issue Date, and any capital stock into which such common stock may thereafter be changed, and shall also include (a) capital stock of the Maker of any other class (regardless of how
denominated) issued to the holders of shares of any common stock upon any reclassification thereof which is also not preferred as to dividends or liquidation over any other class of stock of the Maker and which is not subject to redemption, and
(b) shares of common stock of any successor or acquiring corporation (as provided in Section 4.6 hereof) received by or distributed to the holders of common stock in the circumstances contemplated by Section 4.6 hereof.

 “Conversion Notice” has the meaning set forth therefor in Section 3.2 of this Note. 
 “Conversion Price” means, in respect of a share of Common Stock at any date herein specified, the initial Conversion Price set forth in
Section 3.3 of this Note, as adjusted from time to time pursuant to Section 4 of this Note. 
 “Event of
Default” has the meaning set forth therefor in Section 6.1 of this Note. 
 “Maturity Date” has the
meaning set forth therefor in Section 2.1 of this Note. 
 “Original Issue Date” means that date shown on the
first page of this Note as the Original Issue Date. 
 “Prepayment Date” has the meaning set forth therefor in
Section 2.2.2 of this Note. 
 “Prepayment Notice” has the meaning set forth therefor in
Section 2.2.2 of this Note. 
 “Subsequent Offering” means any sale of any Securities of Maker after the
Original Issue Date, which results in gross proceeds to the Company of at least $5,000,000. 

 2. Payments 
 2.1. Principal and Interest. 
 2.1.1. The principal amount of this Note, together with all unpaid and accrued interest
thereon, shall be due and payable upon the earlier of: (a) January 31, 2007 (the “Maturity Date”) or (b) the Advance Date. 
 2.1.2. In the event those Holders of the 2006 Bridge Notes elect not to convert as provided in Section 3, Maker shall ensure that sufficient funds are set aside from any Subsequent Offering to pay all
amounts due to such Holders of the 2006 Bridge Notes. 
 2.1.3. If the Advance Date shall not have occurred on or prior to the Maturity Date,
then the principal indebtedness evidenced by this Note, together with accrued interest thereon, may at the option of the Payee be converted into shares of Common Stock as provided for in Section 3 of this Note. 
 2.2. Prepayment. 
 2.2.1.
Maker’s Right To Make Prepayments. Maker may, without premium or penalty, at any time and from time to time, prepay all or any portion of the outstanding principal balance due under this Note; provided, that each such prepayment is
accompanied by accrued interest on the amount of principal prepaid calculated to the date of such prepayment. 
 2.2.2. Procedure. In
order to make any prepayment hereunder, the Maker shall provide written notice to the Payee, not more than ten (10) business days and not less than eight (8) business days prior to the prepayment (the “Prepayment Notice”).
The Prepayment Notice must state: (i) the amount to be pre-paid; and (ii) the date on which the prepayment will be made (the “Prepayment Date”). 
 2.3. Pro-rata Payments. The Maker may not make any payment due under this Note, including prepayments hereon, unless the Maker makes a
simultaneous pro-rata payment to the holders of all of the 2006 Bridge Notes (excluding 2006 Bridge Notes where the holder thereof elects to convert upon such prepayment). Nothing in this section shall be deemed to relieve the Maker of it
obligations to make payments hereunder. If Maker is prohibited from making a payment due under this Note, an Event of Default pursuant to Section 6.1 of this Note will occur. 
 3. Conversion into Common Stock. 
 3.1. Conversion. As provided in Section 3.2, the
Payee may, in its sole discretion, elect to convert all or a portion of the outstanding principal amount of this Note then outstanding, together with any accrued interest thereon, into shares of the Common Stock, at the Conversion Price subject to
adjustments as provided in Section 4 of this Note. 
 3.2. Procedure. In order to make an election to convert pursuant to
Section 3.1 of this Note, the Payee shall provide written notice of Payee’s election to the Maker at any time on or after the Maturity Date (the “Conversion Notice”). The Conversion Notice must state the amount of
principal and accrued interest thereon to be converted. Five (5) days after the Conversion Notice is received by the Maker, the entire amount of principal and accrued interest thereon listed in the Conversion Notice shall be converted into
shares of Common Stock based upon the Conversion Price (as may be adjusted), at which time this Note shall be deemed paid in 

 
full and cancelled, subject only to (i) delivery of a stock certificate or stock certificates for the shares of Common Stock issuable upon conversion
hereof and the payment by the Maker of any cash amount due for fractional shares; and (ii) payment of any outstanding principal and interest accrued thereon not converted hereunder; which shall occur against surrender of this Note by the Payee.

 3.3. Conversion Price. For purposes of this Note, the “Conversion Price” shall mean $1.50 per share of Common
Stock. The Conversion Price shall be adjusted from time to time in accordance with the provisions of Section 4 of this Note. 
 3.4. Fractional Shares. No fractional shares of Common Stock shall be issuable upon conversion of this Note, but a payment in cash will be made in respect of any fraction of a share which would otherwise be issuable upon the
surrender of this Note, or portion hereof, for conversion. 
 3.5. Securities Act of 1933 
 3.5.1. Restrictions On Transfer. Neither this Note nor any shares of Common Stock issued upon the conversion hereof shall be transferred, sold,
assigned, exchanged, mortgaged, pledged, hypothecated or otherwise disposed of or encumbered (each, a “Transfer”) without compliance with the provisions of, and are otherwise restricted by, the provisions of, the Securities Act and
this Note. Each certificate, if any, evidencing such shares of Common Stock issued upon any such Transfer, other than in a public offering pursuant to an effective registration statement, shall bear the restrictive legend set forth in
Section 3.5.2, and each Note issued upon such Transfer shall bear a restrictive legend substantially similar to the legend set forth above on this Note, unless the Payee delivers to the Maker an opinion of counsel reasonably satisfactory
to the Maker to the effect that such legend is not required for the purposes of compliance with the Securities Act. Holders of the Notes or such Common Stock, as the case may be, shall not be entitled to Transfer such Notes or such Common Stock
except in accordance with this Section. 
 3.5.2. Restrictive Legends. (a) Except as otherwise provided in this
Section 3.5, each certificate for Common Stock initially issued upon the conversion of this Note, and each certificate for Common Stock issued to any subsequent transferee of any such certificate, shall be stamped or otherwise imprinted
with the legend in substantially the following form: 
 “THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR ANY STATE SECURITIES LAW. THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE TRANSFERRED, SOLD, ASSIGNED, EXCHANGED, MORTGAGED, PLEDGED, HYPOTHECATED OF OTHERWISE DISPOSED OF OR
ENCUMBERED WITHOUT COMPLIANCE WITH THE PROVISIONS OF, AND ARE OTHERWISE RESTRICTED BY THE PROVISIONS OF, THE ACT AND THE RULES AND REGULATIONS THEREUNDER. 

 3.5.3. Termination of Securities Law Restrictions. Notwithstanding the foregoing provisions of
this Section 3.5, the restrictions imposed by Section 3.5 upon the transferability of this Note and the Common Stock and the legend requirements of Section 3.5 shall terminate as to any particular Note or shares
of Common Stock when the Maker shall have received from the Payee thereof an opinion of counsel reasonably satisfactory to the Maker to the effect that such legend is not required in order to ensure compliance with the Securities Act. Whenever the
restrictions imposed by this Section shall terminate as to this Note, as hereinabove provided, the Payee hereof shall be entitled to receive from the Maker, at the expense of the Maker, a new Note bearing the following legend in place of the
restrictive legend set forth hereon: 
 “THE RESTRICTIONS ON TRANSFERABILITY OF THE WITHIN NOTE CONTAINED IN SECTION 3.5 HEREOF
TERMINATED ON                         , 200  , AND ARE OF NO FURTHER FORCE AND EFFECT.” 

All Notes issued upon registration of transfer, division or combination of, or in substitution for, any Note or Notes entitled to bear such legend
shall have a similar legend endorsed thereon. Whenever the restrictions imposed by this Section 3.5 shall terminate as to any share of Common Stock, as hereinabove provided, the holder thereof shall be entitled to receive from the Maker,
at the Maker’s expense, a new certificate representing such Common Stock not bearing the restrictive legend set forth in this Section. 
 3.5.4. Representation. The Payee of this Note, by acceptance hereof, acknowledges and represents that (i) this Note and the shares of Common Stock to be issued upon conversion hereof are being acquired solely for the
Payee’s own account and not as a nominee for any other party and for investment, (ii) the Payee will not offer, sell or otherwise dispose of this Note or any shares of Common Stock to be issued upon conversion hereof except under
circumstances that will not result in a violation of the Securities Act or any state securities laws and (iii) the Payee is an “accredited investor” as that term is defined in Regulation D promulgated under the Securities Act. Upon
conversion of this Note, the Payee shall, if requested by the Maker, confirm in writing, in form satisfactory to the Maker, that the shares of Common Stock issued as a result thereof are being acquired solely for such Payee’s own account and
not as a nominee for any other party, for investment, and not with a view toward distribution or resale. 
 4. Adjustment To Conversion Price.

 The Conversion Price of this Note shall be subject to adjustment from time to time upon the occurrence of certain events, as follows:

 4.1. Failure to Complete Subsequent Offering. If the Maker fails to complete the Subsequent Offering by October 31, 2006 and
the Conversion Price then in effect is greater than $1.00, then the Conversion Price shall forthwith be reduced to $1.00 per share. 
 4.2.
Adjustment Upon Future Issuance. If the Maker shall, at any time or from time to time after the Original Issue Date, issue Additional Shares of Common Stock, options to purchase or rights to subscribe for Additional Shares of Common Stock,
securities by their terms convertible into or exchangeable for Additional Shares of Common Stock, or options to 

 
purchase or rights to subscribe for such convertible or exchangeable securities, without consideration or for consideration per share less than the
Conversion Price in effect immediately prior to the issuance of such Additional Shares of Common Stock or securities, then the Conversion Price in effect immediately prior to each such issuance shall forthwith (except as provided in this
Section 4) be reduced on a weighted average basis effective concurrently with such issuance; provided, however, that the foregoing shall not be applicable to any issuances pursuant to the Company’s 2005 Equity Incentive Plan, the
Company’s Consultant Stock Compensation Plan or the exercise or conversion of any outstanding options, warrants or other outstanding convertible securities. 
 4.3. Calculation of Consideration. For the purposes of any adjustment of a Conversion Price pursuant to Section 4.2 of this Note, the following provisions shall be applicable: 
 4.3.1. In the case of the issuance of Additional Shares of Common Stock for cash in a public offering or private placement, the consideration shall be
deemed to be the amount of cash paid therefor before deducting therefrom any discounts, commissions or placement fees payable by the Maker to any underwriter or placement agent in connection with the issuance and sale thereof. 
 4.3.2. In the case of the issuance of Additional Shares of Common Stock for a consideration in whole or in part other than cash, the consideration other
than cash shall be deemed to be the fair market value thereof. 
 4.3.3. In the case of the issuance of Additional Shares of Common Stock for
no consideration, the Maker and the Payee shall mutually in good faith agree upon an amount of consideration per share to use in these calculations. 
 4.3.4. In the case of the issuance of options to purchase or rights to subscribe for Additional Shares of Common Stock, securities by their terms convertible into or exchangeable for Additional Shares of Common Stock,
or options to purchase or rights to subscribe for such convertible or exchangeable securities: 
 a. the aggregate maximum number of shares of
Common Stock deliverable upon exercise of such options to purchase or rights to subscribe for Additional Shares of Common Stock shall be deemed to have been issued at the time such options or rights were issued and for a consideration equal to the
consideration (determined in the manner provided in subsections 4.3.1 and 4.3.2 of this Note), if any, received by the Maker upon the issuance of such options or rights plus the minimum purchase price provided in such options or rights for
the Common Stock covered thereby; 
 b. the aggregate maximum number of shares of Common Stock deliverable upon conversion of or in exchange
of any such convertible or exchangeable 

 
securities or upon the exercise of options to purchase or rights to subscribe for such convertible or exchangeable securities and subsequent conversion or
exchange thereof shall be deemed to have been issued at the time such securities, options, or rights were issued and for a consideration equal to the consideration received by the Maker for any such securities and related options or rights
(excluding any cash received on account of accrued interest or accrued dividends), plus the additional consideration, if any, to be received by the Maker upon the conversion or exchange of such securities or the exercise of any related options or
rights (the consideration in each case to be determined in the manner provided in subsections 4.3.1 and 4.3.2 of this Note); 
 c. on
any change in the number of shares or exercise price for Common Stock deliverable upon exercise of any such options or rights or conversions of or exchanges for such securities, other than a change resulting from the anti-dilution provisions
thereof, the applicable Conversion Price shall forthwith be readjusted to such Conversion Price as would have been obtained had the adjustment made upon the issuance of such options, rights or securities not converted prior to such change or options
or rights related to such securities not converted prior to such change been made upon the basis of such change; 
 d. no further adjustment
of the Conversion Price adjusted upon the issuance of any such options, rights, convertible securities or exchangeable securities shall be made as a result of the actual issuance of Common Stock on the exercise of any such rights or options or any
conversion or exchange of any such securities; and 
 e. on the expiration of any such options or rights, the termination of any such rights
to convert or exchange or the expiration of any options or rights related to such convertible or exchangeable securities, the Conversion Price shall forthwith be readjusted to such Conversion Price as would have been obtained had the adjustment made
upon the issuance of such options, rights, securities or options or rights related to such securities been made upon the basis of the issuance of only the number of shares of Common Stock actually issued upon the exercise of such options or rights,
upon the conversion or exchange of such securities or upon the exercise of the options or rights related to such securities and subsequent conversion or exchange thereof. 
 4.4. Adjustment Upon Stock Dividends, Subdivisions or Splits. If, at any time after the Original Issue Date, the number of shares of Common Stock outstanding is increased by a stock dividend payable in shares
of Common Stock or by a subdivision or split-up of shares of Common Stock, then, following the record date for the determination of holders of Common Stock entitled to receive such stock dividend, or to be affected by such subdivision or split-up,
the Conversion Price shall be appropriately decreased so that the number of shares of Common Stock issuable on conversion of this Note shall be increased in proportion to such increase in outstanding shares. 

 4.5. Adjustment Upon Combinations. If, at any time after the Original Issue Date, the number of
shares of Common Stock outstanding is decreased by a combination of the outstanding shares of Common Stock into a smaller number of shares of Common Stock, then, following the record date to determine shares affected by such combination, the
Conversion Price shall be appropriately increased and the number of shares of Common Stock issuable upon conversion of this Note shall be appropriately decreased in proportion to such decrease in outstanding shares. 
 4.6. Adjustment Upon Reclassifications, Reorganizations, Consolidations or Mergers. In the event of any capital reorganization of the Maker, any
reclassification of the stock of the Maker (other than a change in par value or from par value to no par value or from no par value to par value or as a result of a stock dividend or subdivision, split-up or combination of shares), or any
consolidation or merger of the Maker with or into another corporation (where the Maker is not the surviving corporation or where there is a change in or distribution with respect to the Common Stock), this Note shall after such reorganization,
reclassification, consolidation, or merger be exercisable for the kind and number of shares of stock or other securities or property of the Maker or of the successor corporation resulting from such consolidation or surviving such merger, if any, to
which the holder of the number of shares of Common Stock deliverable (immediately prior to the time of such reorganization, reclassification, consolidation or merger) upon conversion of this Note would have been entitled upon such reorganization,
reclassification, consolidation or merger. The provisions of this clause shall similarly apply to successive reorganizations, reclassifications, consolidations, or mergers. 
 4.7. Deferral of Adjustment In Certain Circumstances. In any case in which the provisions of this Section 4 shall require that an
adjustment shall become effective immediately after a record date of an event, the Maker may defer until the occurrence of such event issuing to the Payee after such record date and before the occurrence of such event the shares of capital stock
issuable upon such conversion by reason of the adjustment required by such event and issue to such Payee only the shares of capital stock issuable upon such conversion before giving effect to such adjustments, provided, however, that the Maker shall
deliver to such Payee an appropriate instrument or due bills evidencing such Payee’s right to receive such additional shares. 
 4.8.
Notice of Adjustment of Conversion Price. Whenever the Conversion Price is adjusted as herein provided: 
 4.8.1. the Maker shall
compute the adjusted Conversion Price in accordance with this Section 4 and prepare a certificate signed by the Controller or Chief Financial Officer of the Maker setting forth the adjusted Conversion Price showing in reasonable detail
the facts upon which such adjustment is based, and such certificate shall forthwith be filed at each office or agency maintained for such purpose; and 
 4.8.2. a notice stating that the Conversion Price for which this Note is convertible has been adjusted and setting forth the adjusted Conversion Price shall forthwith be prepared by the Maker, and as soon as
practicable after it is prepared, such notice shall be mailed by the Maker at its expense to Payee. 

 5. Warrants Coverage. 
 Simultaneous with the delivery of this Note, the Maker shall also issue to the Payee warrants (the “Warrant”) exercisable for the Common Stock in substantially the form of Exhibit A
attached hereto and incorporated herein. The Warrant shall be exercisable for that number of shares of Common Stock calculated as follows: (i) thirty percent (30%) of the principal amount of this Note; divided by (ii) $1.50, subject
to anti-dilution provisions contained. 

 6. Defaults 
 6.1. Events of Default. The occurrence of any one or more of the following events with respect to Maker shall constitute an event of default hereunder (“Event of Default”): 
 a. If Maker shall fail to pay when due any payment of principal or interest on this Note and such failure continues for five (5) business days
following written demand thereof from Payee. 
 b. If Maker shall fail to observe or perform any other of the agreements or covenants of Maker
herein contained or contained in the Warrant and such failure continues for twenty (20) days following written demand thereof from Payee. 
 c. There exists a default or an event that, with the giving of notice, would constitute a default under any other indebtedness of Maker or any subsidiary for borrowed money. 
 d. If, pursuant to or within the meaning of the United States Bankruptcy Code or any other federal or state law relating to insolvency or relief of
debtors (a “Bankruptcy Law”), Maker or any subsidiary of Maker shall (i) commence a voluntary case or proceeding; (ii) consent to the entry of an order for relief against it in an involuntary case; (iii) consent to
the appointment of a trustee, receiver, assignee, liquidator or similar official; (iv) make an assignment for the benefit of its creditors; or (v) admit in writing its inability to pay its debts as they become due. 
 e. The entry of a final judgment for payment against Maker in an amount exceeding $100,000 which shall not have been discharged or execution thereof
stayed pending appeal or shall not have been discharged within 45 days after the expiration of any stay. 
 f. If a court of competent
jurisdiction enters an order or decree under any Bankruptcy Law that (i) is for relief against Maker in an involuntary case, (ii) appoints a trustee, receiver, assignee, liquidator or similar official for Maker or substantially all of
Maker’s properties, or (iii) orders the liquidation of Maker, and in each case the order or decree is not dismissed within 90 days. 
 g. If the Maker shall sell or otherwise transfer all or substantially all of its assets. 
 6.2. Notice by Maker. Maker shall
notify Payee in writing within five (5) days after the occurrence of any Event of Default of which Maker acquires knowledge. 
 6.3.
Remedies. To the extent that Payee has not converted the debt into Maker’s Common Stock and Maker has not retired the debt in full, upon the occurrence of an Event of 

 
Default hereunder (unless such Event of Default has been cured by Maker or waived by Payee), Payee may, at its option, (i) by written notice to Maker,
declare the entire unpaid principal balance of this Note, together with all accrued interest thereon, immediately due and payable regardless of any prior forbearance, and (ii) exercise any and all rights and remedies available to it under
applicable law, including, without limitation, the right to collect from Maker all sums due under this Note. Maker shall pay all reasonable costs and expenses incurred by or on behalf of Payee in connection with Payee’s exercise of any or all
of its rights and remedies under this Note, including, without limitation, reasonable attorneys’ fees. 
 7. Confession Of Judgment; Waiver Of Jury
Trial 
 7.1. Confession of Judgment. THE FOLLOWING SETS FORTH A WARRANT OF ATTORNEY TO CONFESS JUDGMENT AGAINST MAKER. IN GRANTING
THIS WARRANT OF ATTORNEY TO CONFESS JUDGMENT AGAINST MAKER, MAKER, FOLLOWING CONSULTATION WITH (OR DECISION NOT TO CONSULT WITH) SEPARATE COUNSEL FOR MAKER, AND WITH KNOWLEDGE OF THE LEGAL EFFECT HEREOF, HEREBY WAIVES ANY AND ALL RIGHTS MAKER HAS,
OR MAY HAVE TO PRIOR NOTICE AND AN OPPORTUNITY TO BE HEARD UNDER THE CONSTITUTIONS AND LAWS OF THE UNITED STATES AND THE COMMONWEALTH OF PENNSYLVANIA. MAKER SPECIFICALLY ACKNOWLEDGES THAT PAYEE HAS RELIED ON THIS WARRANT OF ATTORNEY IN GRANTING THE
FINANCIAL ACCOMMODATIONS DESCRIBED HEREIN. 
 MAKER IRREVOCABLY AUTHORIZES AND EMPOWERS ANY ATTORNEY OF ANY COURT OF RECORD TO APPEAR FOR
MAKER IN ANY AND ALL ACTIONS, AND UPON THE OCCURRENCE OF AN EVENT OF DEFAULT TO: (I) ENTER JUDGMENT AGAINST MAKER FOR THE PRINCIPAL SUM HEREOF; OR (II) SIGN FOR MAKER AN AGREEMENT FOR ENTERING IN ANY COMPETENT COURT AN AMICABLE ACTION OR
ACTIONS TO CONFESS JUDGMENT AGAINST MAKER FOR ALL OR ANY PART OF THE INDEBTEDNESS EVIDENCED HEREBY; AND IN EITHER CASE FOR INTEREST AND COSTS TOGETHER WITH A REASONABLE COLLECTION FEE. MAKER FURTHER IRREVOCABLY AUTHORIZES AND EMPOWERS ANY ATTORNEY
OF ANY COURT OF RECORD TO APPEAR FOR AND ENTER JUDGMENT AGAINST MAKER AND IN FAVOR OF PAYEE OR ANY HOLDER HEREOF WITH RESPECT TO AN AMICABLE ACTION OR REPLEVIN OR ANY OTHER ACTION TO RECOVER POSSESSION OF ANY COLLATERAL SECURING THIS NOTE. MAKER
WAIVES ALL RELIEF FROM ANY AND ALL APPRAISEMENT OR EXEMPTION LAWS NOW IN FORCE OR HEREAFTER ENACTED. IF A COPY OF THIS NOTE, VERIFIED BY AFFIDAVIT OF PAYEE OR ANY OTHER HOLDER HEREOF, SHALL BE FILED IN ANY PROCEEDING OR ACTION WHEREIN JUDGMENT IS TO
BE CONFESSED, IT SHALL NOT BE NECESSARY TO FILE THE ORIGINAL HEREOF AND SUCH VERIFIED COPY SHALL BE SUFFICIENT WARRANT FOR ANY ATTORNEY OF THE COURT OF RECORD TO APPEAR FOR AND CONFESS JUDGMENT AGAINST THE MAKER AS PROVIDED HEREIN. JUDGMENT MAY BE
CONFESSED FROM TIME TO TIME UNDER THE AFORESAID POWERS WHICH SHALL NOT BE EXHAUSTED BY ONE EXERCISE THEREOF. 

 7.2. Waiver of Jury Trial. MAKER AND PAYEE EXPRESSLY WAIVE ANY RIGHT TO TRIAL BY JURY IN ANY
ACTION BROUGHT BY ANY PARTY WITH RESPECT TO THIS NOTE OR ANY OTHER DOCUMENT OR INSTRUMENT EVIDENCING OR SECURING INDEBTEDNESS FROM MAKER TO PAYEE. 
 8.
Miscellaneous. 
 8.1. Waiver. The rights and remedies of Payee under this Note shall be cumulative and not alternative. No waiver
by Payee of any right or remedy under this Note shall be effective unless in writing signed by Payee. Neither the failure nor any delay in exercising any right, power or privilege under this Note will operate as a waiver of such right, power or
privilege and no single or partial exercise of any such right, power or privilege by Payee will preclude any other or further exercise of such right, power or privilege or the exercise of any other right, power or privilege. To the maximum extent
permitted by applicable law, (a) no claim or right of Payee arising out of this Note can be discharged by Payee, in whole or in part, by a waiver or renunciation of the claim or right unless in a writing, signed by Payee; (b) no waiver
that may be given by Payee will be applicable except in the specific instance for which it is given; and (c) no notice to or demand on Maker will be deemed to be a waiver or any obligation of Maker or of the right of Payee to take further
action without notice or demand as provided in this Note. Maker hereby waives presentment, demand, protest and notice of dishonor and protest. 
 8.2. Notice Generally. Any notice, demand, request, consent, approval, declaration, delivery or communication hereunder to be made pursuant to the provisions of this Note shall be sufficiently given or made if sent by confirmed
facsimile transmission to the fax number given below or in writing and delivered in person with receipt acknowledged, sent by a recognized overnight courier service, or sent by registered or certified mail, return receipt requested, postage prepaid,
addressed as follows: 
  

					
		 	                                if to Maker:	 	Synova Healthcare Group, Inc.
		 		 	1400 North Providence Road
		 		 	Media, Pennsylvania 19063
		 		 	Attn.: Chief Executive Officer
		 		 	Fax: (610) 565-7081
			
		 	                                if to Payee:	 	c/o The Keystone Equities Group
		 		 	1003 Egypt Road
		 		 	Box 1155
		 		 	Oaks, Pennsylvania 19456-1155
		 		 	Attn.: Mr. William Fretz
		 		 	Fax: (610) 415-6328

 or at such other address as may be substituted by notice given as herein provided. The giving of any notice
required hereunder may be waived in writing by the party entitled to receive such notice. Every notice, demand, request, consent, approval, declaration, delivery or other communication hereunder shall be deemed to have been duly given or served on
the date on 

 
which personally delivered, with receipt acknowledged, or three (3) Business Days after the same shall have been deposited in the United States mail, or
one (1) Business Day after the same shall have been sent by Federal Express or another recognized overnight courier service. 
 8.3.
Severability. If any provision in this Note is held invalid or unenforceable by any court of competent jurisdiction, the other provisions of this Note will remain in full force and effect. Any provision of this Note held invalid or
unenforceable only in part or degree will remain in full force and effect to the extent not held invalid or unenforceable. 
 8.4.
Governing Law. This Note will be governed by the laws of the Commonwealth of Pennsylvania without regard to conflicts of laws principles. 
 8.5. Section Headings, Construction. The headings of Sections in this Note are provided for convenience only and will not affect its construction or interpretation. All references to “Section” or “Sections” refer
to the corresponding Section or Sections of this Note unless otherwise specified. All words used in this Note will be construed to be of such gender or number as the circumstances require. Unless otherwise expressly provided, the words
“hereof” and “hereunder” and similar references refer to this Note in its entirety and not to any specific section or subsection hereof. 
 [Remainder of Page Intentionally Blank] 

 IN WITNESS WHEREOF, Maker has executed and delivered this Note as of the date first stated above.

  

			
	MAKER:
	
	Synova Healthcare Group, Inc.
		
	By:	 	  

	Name:	 	  

	Title:	 	  

 EXHIBIT A 
 to 
 Promissory Note dated October     , 2006 
 Made by 
 Synova Healthcare Group, Inc.,Form of Convertible Note Purchase Agreement, dated as of October 2006

 EXHIBIT 4.33 
 CONVERTIBLE NOTE PURCHASE AGREEMENT 
 THIS CONVERTIBLE NOTE PURCHASE AGREEMENT (this
“Agreement”), is made on this      day of October, 2006, by and among Synova Healthcare Group, Inc., a Nevada corporation (the “Company”), and each of the parties listed on Schedule
1.1 attached hereto (each a “Purchaser” and collectively the “Purchasers”). As a matter of convenience, in the event that this Agreement relates to one sole Purchaser rather than multiple Purchasers, any
references to “Purchasers” herein shall refer to such sole Purchaser. 
 RECITALS 
 WHEREAS, this Agreement is one in a series of agreements relating to the offer and sale by the Company (the “Offering”) of up to
an aggregate of $2,000,000 of the Company’s 2006 Convertible Bridge Notes (each a “Note” and all of the 2006 Convertible Bridge Notes issued pursuant to this Offering, the “Notes”), the form of which is
attached hereto as Exhibit A, together with Common Stock Warrants (each a “Warrant” and all of the Common Stock Warrants, the “Warrants”), the form of which is attached hereto as Exhibit B; 

AGREEMENT 
 NOW,
THEREFORE, in consideration of the foregoing premises, the premises, covenants and conditions set forth herein, and certain other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, and intending to be
legally bound, the parties hereby agree as follows: 
 ARTICLE I 
 DEFINITIONS 
 1.1. Definitions. In addition to the terms defined elsewhere in this Agreement, for all
purposes of this Agreement, the following terms have the meanings indicated in this Section 1.1: 
 “Affiliate” means any Person that, directly or indirectly through one or more intermediaries, controls or is controlled by or is under common control with a Person as such terms are used in and construed under Rule 144.
With respect to a Purchaser, any investment fund or managed account that is managed on a discretionary basis by the same investment manager as such Purchaser will be deemed to be an Affiliate of such Purchaser. 
 “Closing” means the closing of the purchase and sale of the Notes and Warrants pursuant to Section 2.3.

 “Closing Date” means the Trading Day when all of the Transaction Documents have been executed and
delivered by the applicable parties thereto, and all conditions precedent to (i) the Purchasers’ obligations to pay the Note Amount and (ii) the Company’s obligations to deliver the Notes and Warrants have been satisfied or
waived. 

 “Commission” means the United States Securities and Exchange Commission.

 “Common Stock” means the common stock of the Company, $.001 par value per share. 
 “Effective Date” means the date that the Registration Statement is first declared effective by the Commission.

 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 
 “Liens” means a lien, charge, security interest, encumbrance, right of first refusal, preemptive right or other
restriction. 
 “Material Adverse Effect” shall have the meaning ascribed to such term in
Section 3.1(b). 
 “Note” shall have the meaning ascribed to such term in the recital.

 “Note Amount” means, as to each Purchaser, the amounts set forth below such Purchaser’s signature on
the signature page hereto, in United States dollars and in immediately available funds. 
 “Note Shares”
means the shares of common stock issuable upon conversion of the Notes. 
 “Person” means an individual or
corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity of any kind. 
 “Principal Market” initially means The OTC Bulletin Board and shall also include the NASDAQ Small-Cap Market, the New
York Stock Exchange, the Nasdaq National Market or the American Stock Exchange, whichever is at the time the principal trading exchange or market for the Common Stock, based upon share volume. 
 “Proceeding” means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation
or partial proceeding, such as a deposition), whether commenced or threatened. 
 “Registration Rights
Agreement” means the Registration Rights Agreement, dated as of the date of this Agreement, among the Company and each Purchaser, in the form of Exhibit C hereto. 
  

 2 

 “Registration Statement” means a registration statement meeting the
requirements set forth in the Registration Rights Agreement and covering the resale by the Purchasers of the Note Shares and the Warrant Shares. 
 “Required Approvals” shall have the meaning ascribed to such term in Section 3.1(e). 
 “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the
Commission having substantially the same effect as such Rule. 
 “SEC Reports” shall have the meaning
ascribed to such term in Section 3.1(g). 
 “Securities Act” means the Securities Act of 1933, as
amended. 
 “Subsidiary” shall mean the subsidiaries of the Company, if any, referenced in
Section 3.1(a). 
 “Trading Day” means a day on which the Common Stock is traded on a Principal
Market. 
 “Transaction Documents” means this Agreement, the Registration Rights Agreement, the Notes, any
Warrants and any other documents or agreements executed in connection with the transactions contemplated hereunder. 
 “Warrants” means the warrants issued to each Purchaser to purchase shares of Common Stock, in the form of Exhibit B hereto. 
 “Warrant Shares” means the shares of Common Stock issuable upon exercise of the Warrants. 
 ARTICLE II 
 PURCHASE, SALE AND CLOSING

 2.1. Sale and Purchase of the Notes and the Warrants. The Company agrees to sell to each Purchaser and each Purchaser agrees to
purchase from the Company, a Note and a Warrant, with the Note being in the principal amount set forth below such Purchaser’s signature on the signature page, in United States dollars and with the Warrant being exercisable into the number of
Warrant Shares determined by the following formula: (i) the Note Amount multiplied by 30% divided by (ii) the exercise price as adjusted from time to time as provided in the Warrant. 
 2.2. Purchase Price. The aggregate purchase price to be paid by the Purchasers for the Notes and Warrants at the Closing shall be up to Two
Million Dollars ($2,000,000) (the “Purchase Price”). 
  

 3 

 2.3. Closing Date. Subject to the satisfaction of the conditions set forth in
Section 2.5 hereof (or the waiver thereof by the party entitled to waive that condition), the closing of the purchase and sale of the Notes and the Warrants provided for in Section 2.1 hereof (the “Closing”)
shall take place at 10:00 a.m. at the offices of the Company, 1400 North Providence Road, Building II, Suite 6010, Media, Pennsylvania on the date hereof, or at such other place and on such other date as the Company and the Purchasers may mutually
agree. The date on which the Closing shall be held is referred to in this Agreement as the “Closing Date.” 
 2.4.
Delivery of Note and Warrant. At the Closing, (i) the Company shall deliver to each Purchaser the applicable Note and Warrant, against payment by such Purchaser of the Note Amount by wire transfer of immediately available funds to an
account designated in writing by the Company or by such other method as the Company and the Purchasers may mutually agree and (ii) the parties shall make the other deliveries provided in Section 2.5 hereof. 
 2.5. Closing Conditions; Deliveries. 
 (a) On the Closing Date, the Company shall deliver or cause to be delivered to each Purchaser the following: 
 (i) this Agreement
duly executed by the Company; 
 (ii) the Note duly executed by the Company; 
 (iii) the Warrant duly executed by the Company; and 
 (iv) the Registration Rights Agreement duly executed by the Company. 
 (b) On the Closing Date, each
Purchaser shall deliver or cause to be delivered to the Company the following: 
 (i) this Agreement duly executed by such Purchaser;

 (ii) such Purchaser’s Note Amount by wire transfer to the account as specified in writing by the Company; and 
 (iii) the Registration Rights Agreement duly executed by such Purchaser. 
 (c) The obligations of the parties are subject to the following additional conditions: 
 (i) All
representations and warranties of the other party contained herein shall remain true and correct as of the Closing Date and all covenants of the other party shall have been performed if due prior to such date. 
  

 4 

 (ii) From the date hereof to the Closing Date, trading in the Common Stock shall not have been suspended
by the Commission (except for any suspension of trading of limited duration agreed to by the Company, which suspension shall be terminated prior to the Closing), and, at any time prior to the Closing Date, trading in securities generally as reported
by Bloomberg Financial Markets shall not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service, or on any Principal Market, nor shall a banking moratorium have been
declared either by the United States or New York State authorities nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude in its effect on, or any material
adverse change in, any financial market which, in each case, in the reasonable judgment of each Purchaser, makes it impracticable or inadvisable to purchase the Notes at the Closing. 
 (iii) There shall not then be in effect any legal or other order enjoining or restraining the transactions contemplated by this Agreement. 

(iv) There shall not be in effect any law, rule or regulation prohibiting or restricting such sale or requiring any consent or approval of any person
to issue the Notes, the Note Shares, the Warrant or Warrant Shares which consent or approval shall not have been obtained (except as may otherwise be provided in this Agreement). 
 ARTICLE III 
 REPRESENTATIONS AND WARRANTIES 
 3.1. Representations and Warranties of the Company. Except as set forth in the SEC Reports, the Company hereby makes the representations and
warranties set forth below to each Purchaser: 
 (a) Subsidiaries. All of the direct and indirect subsidiaries of the Company are
referenced in the SEC Reports. The Company owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and all the issued and outstanding shares of capital stock of each Subsidiary
are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to subscribe for or purchase securities. 
 (b) Organization and Qualification. Each of the Company and the Subsidiaries is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or
organization (as applicable), with the requisite power and authority to own and use its properties and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation or default of any of the
provisions of its respective certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries is duly qualified to conduct business and is in good standing as a foreign
corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, could not
have or reasonably be expected to result in (i) a material adverse effect on the legality, validity or enforceability of any Transaction Document, (ii) a material adverse effect on the results of operations, assets, business or financial
condition of the Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability 

  

 5 

 
to perform in any material respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material
Adverse Effect”) and no Proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. 
 (c) Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by each of the Transaction Documents and otherwise to carry out its obligations thereunder. The execution and delivery of each of the Transaction Documents by the Company and the consummation by it of the transactions contemplated
thereby have been duly authorized by all necessary action on the part of the Company and no further action is required by the Company in connection therewith other than in connection with the Required Approvals. Each Transaction Document has been
(or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms hereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with its terms
except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of
specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may be limited by applicable law. 
 (d) No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company, the issuance and sale of the Notes and
Warrant and the consummation by the Company of the other transactions contemplated thereby do not and will not (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles of incorporation,
bylaws or other organizational or charter documents, or (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would become a default) under, result in the creation of any Lien upon any of the
properties or assets of the Company or any Subsidiary, or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both) of, any agreement, credit facility, debt or other instrument
(evidencing a Company or Subsidiary debt or otherwise) or other understanding to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected, or (iii) subject to the
Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary is subject (including
federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to
result in a Material Adverse Effect. 
 (e) Filings, Consents and Approvals. The Company is not required to obtain any consent,
waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal, state, local or other governmental authority or other Person in connection with the execution, delivery and performance by
the Company of the Transaction Documents, other than the filing of Form D with the Commission and such filings as are required to be made under applicable federal and state securities laws (collectively, the “Required Approvals”).

  

 6 

 (f) Issuance or Conversion. On the date upon which Notes are converted to the Note Shares, and on
each date on which the Warrants are exercised, the Note Shares and Warrant Shares (as case may be) shall be duly authorized and, when issued and paid for in accordance with the Transaction Documents, will be duly and validly issued, fully paid and
nonassessable, free and clear of all Liens imposed by the Company other than restrictions on transfer provided for in the Transaction Documents. The Company has reserved from its duly authorized capital stock the maximum number of shares of Common
Stock issuable pursuant to this Agreement. The issuance and sale of the Notes, Note Shares, Warrants or Warrant Shares contemplated hereby will not give rise to any preemptive rights or rights of first refusal on behalf of any Person. 
 (g) SEC Reports; Financial Statements. The Company has filed all reports required to be filed by it under the Securities Act and the Exchange Act,
including pursuant to Section 13(a) or 15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law to file such material) (the foregoing materials, including the exhibits
thereto, being collectively referred to herein as the “SEC Reports”) on a timely basis (except for certain Forms 8-K, which may not have been timely filed) or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange Act and the rules and regulations of the
Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in
light of the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the
Commission with respect thereto as in effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods involved
(“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material
respects the financial position of the Company and its consolidated subsidiaries as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal,
immaterial, year-end audit adjustments. 
 (h) Material Changes. Since the date of the latest audited financial statements included
within the SEC Reports, except as specifically disclosed in the SEC Reports, there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse Effect. 
 (i) Sarbanes-Oxley; Internal Accounting Controls. The Company is in material compliance with all provisions of the Sarbanes-Oxley Act of 2002 and
the rules promulgated there under which are applicable to it as of the Closing Date. 
  

 7 

 (j) Certain Fees. Except for The Keystone Equities Group, L.P. (“Placement
Agent”), no brokerage or finder’s fees or commissions are or will be payable by the Company to any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the
transactions contemplated by this Agreement. 
 (k) Private Placement. Assuming the accuracy of the Purchasers’ representations
and warranties set forth in Section 3.2, no registration under the Securities Act is required for the offer and sale of the Notes or the Warrants by the Company to the Purchasers as contemplated hereby. The issuance and sale of the
Notes, Note Shares and the Warrants hereunder does not contravene the rules and regulations of the Principal Market. 
 (l) Investment
Company. The Company is not, and is not an Affiliate of, and immediately after receipt of payment for the Notes, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company Act of 1940, as
amended. 
 (m) Listing and Maintenance Requirements. The Company’s Common Stock is registered pursuant to
Section 12(g) of the Exchange Act, and the Company has taken no action designed to, or which to its knowledge is likely to have the effect of, terminating the registration of the Common Stock under the Exchange Act nor has the Company
received any notification that the Commission is contemplating terminating such registration. The Company has not, in the 12 months preceding the date hereof, received notice from any Principal Market on which the Common Stock is or has been listed
or quoted to the effect that the Company is not in compliance with the listing or maintenance requirements of such Principal Market. The Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in
compliance in all material respects with all such listing and maintenance requirements. 
 (n) Application of Takeover Protections.
The Company and its Board of Directors have taken all necessary action, if any, in order to render inapplicable to the issuance of the Notes, the Note Shares and the Warrant Shares any control share acquisition, business combination, poison pill
(including any distribution under a rights agreement) or other similar anti-takeover provision under the Company’s Certificate of Incorporation (or similar charter documents) or the laws of its state of incorporation that is or could become
applicable to the Purchasers as a result of the Purchasers and the Company fulfilling their obligations or exercising their rights under the Transaction Documents. 
 (o) Disclosure. The Company confirms that, neither the Company nor any other Person acting on its behalf has provided any of the Purchasers or their agents or counsel with any information that constitutes or
might constitute material, non-public information. The Company understands and confirms that the Purchasers will rely on the foregoing representations and covenants in effecting transactions in securities of the Company. The Company acknowledges and
agrees that no Purchaser makes or has made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in Section 3.2 hereof. 
 (p) No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2,
neither the Company, nor any of its 

  

 8 

 
affiliates, nor any Person acting on its or their behalf has, directly or indirectly, made any offers or sales of any security or solicited any offers to buy
any security, under circumstances that would cause this offering of the Notes, Note Shares, Warrant and Warrant Shares to be integrated with prior offerings by the Company for purposes and in violation of the Securities Act or any applicable
shareholder approval provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on which any of the securities of the Company are listed or designated. 
 (q) General Solicitation. Neither the Company or, the Company’s knowledge, any person acting on behalf of the Company, has offered or sold
any of the Notes or Warrants by any form of general solicitation or general advertising. The Company has offered the Notes and the Warrants for sale only to the Purchasers and certain other persons that the Company reasonably believes are
“accredited investors” within the meaning of Rule 501 under the Securities Act. 
 (r) Acknowledgment Regarding Purchasers’
Purchase of Shares. The Company acknowledges and agrees that each of the Purchasers is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby. The
Company further acknowledges that no Purchaser is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated hereby and any advice given by any Purchaser or
any of their respective representatives or agents in connection with this Agreement and the transactions contemplated hereby is merely incidental to the Purchasers’ purchase of the Notes and Warrants. The Company further represents to each
Purchaser that the Company’s decision to enter into this Agreement has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives. 
 3.2. Representations and Warranties of the Purchasers. Each Purchaser hereby, for itself and for no other Purchaser, represents and warrants as of
the date hereof and as of the Closing Date to the Company as follows: 
 (a) Organization; Authority. Such Purchaser is an entity duly
organized, validly existing and in good standing under the laws of the jurisdiction of its organization with full right, corporate or partnership power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents and otherwise to carry out its obligations thereunder. The execution, delivery and performance by such Purchaser of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate or similar action on
the part of such Purchaser. Each Transaction Document to which it is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation
of such Purchaser, enforceable against it in accordance with its terms, except (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and other laws of general application affecting
enforcement of creditors’ rights generally, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions
may be limited by applicable law. 
  

 9 

 (b) No Conflicts. The execution, delivery and performance of the Transaction Documents by such
Purchaser, the issuance and sale of the Notes and Warrant to such Purchaser and the consummation by such Purchaser of the other transactions contemplated thereby do not and will not (i) conflict with or violate any provision of such
Purchaser’s certificate or articles of incorporation, bylaws or other organizational or charter documents, or (ii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment,
injunction, decree or other restriction of any court or governmental authority to which such Purchaser is subject (including federal and state securities laws and regulations), or by which any property or asset of such Purchaser is bound or
affected. 
 (c) Investment Intent. Such Purchaser understands that the Notes, Note Shares, Warrants and Warrant Shares are
“restricted securities” and have not been registered under the Securities Act or any applicable state securities law and is acquiring such securities as principal for its own account for investment purposes only and not with a view to or
for distributing or reselling such securities or any part thereof, has no present intention of distributing any of such securities and has no arrangement or understanding with any other persons regarding the distribution of such securities (this
representation and warranty not limiting such Purchaser’s right to sell such securities pursuant to the Registration Statement or otherwise in compliance with applicable federal and state securities laws). Such Purchaser is acquiring such
securities hereunder in the ordinary course of its business. Such Purchaser does not have any agreement or understanding, directly or indirectly, with any Person to distribute any of such securities. 
 (d) Purchaser Status. At the time such Purchaser was offered the Notes, Note Shares, Warrants and Warrant Shares it was, at the date hereof and on
each date on which it exercises any of the Warrants or converts any Notes it will be, either: (i) an “accredited investor” as defined in Rule 501(a)(1), (a)(2), (a)(3), (a)(7) or (a)(8) under the Securities Act or (ii) a
“qualified institutional buyer” as defined in Rule 144A(a) under the Securities Act. Such Purchaser is not required to be registered as a broker-dealer under Section 15 of the Exchange Act. 
 (e) Experience of Such Purchaser. Such Purchaser, either alone or together with its representatives, has such knowledge, sophistication and
experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective investment in the Notes, Note Shares, Warrants and Warrant Shares, and has so evaluated the merits and risks of such investment.
Such Purchaser is able to bear the economic risk of an investment in securities and, at the present time, is able to afford a complete loss of such investment. 
 (f) General Solicitation. Such Purchaser is not purchasing the Notes, Note Shares, Warrants and Warrant Shares as a result of any advertisement, article, notice or other communication regarding such securities
published in any newspaper, magazine or similar media or broadcast over television or radio or presented at any seminar or any other general solicitation or general advertisement. 
  

 10 

 (g) Ownership of Company Stock. The purchase by each Purchaser of the Notes, Note Shares, Warrants
and Warrant Shares is issuable to it at the Closing will not result in such Purchaser (individually or together with other Persons with whom such Purchaser has identified, or will have identified, itself as part of a “group” in a public
filing made with the Commission involving the Company’s securities) acquiring, or obtaining the right to acquire, in excess of 9.999% of the Common Stock or the voting power of the Company on a post transaction basis that assumes that the
Closing shall have occurred. 
 The Company acknowledges and agrees that each Purchaser does not make or has not made any
representations or warranties with respect to the transactions contemplated hereby other than those specifically set forth in this Section 3.2. 
 ARTICLE IV 
 OTHER AGREEMENTS OF THE PARTIES 
 4.1. Transfer Restrictions. The Notes, Note Shares, Warrants and Warrant Shares may only be disposed of in compliance with state and federal
securities laws. In connection with any transfer of such securities other than pursuant to an effective registration statement or Rule 144, the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by
the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Notes, Note Shares,
Warrants or Warrant Shares under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and shall have the rights of a Purchaser under this Agreement and the Registration
Rights Agreement. 
 4.2. Furnishing of Information. As long as any Purchaser owns Notes, Note Shares, Warrant or Warrant Shares, the
Company covenants to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act. As long as any Purchaser owns
Notes, Note Shares, Warrants and Warrant Shares, if the Company is not required to file reports pursuant to the Exchange Act, it will prepare and furnish to the Purchasers and make publicly available in accordance with Rule 144(c) such information
as is required for the Purchasers to sell such shares under Rule 144. The Company further covenants that it will take such further action as any holder of Notes and Warrants may reasonably request, all to the extent required from time to time to
enable such Person to sell such Note Shares or Warrant Shares without registration under the Securities Act within the limitation of the exemptions provided by Rule 144. 
 4.3. Reimbursement. Upon a written undertaking satisfactory to the Company from any Purchaser or Placement Agreement that it will repay any amounts paid pursuant to this Section 4.3 upon a final
determination of a court of competent jurisdiction that such persons were not entitled to such reimbursement or indemnification pursuant to Section 4.4, if any Purchaser or Placement Agent becomes involved in any capacity in any Proceeding by
or against any Person who is a stockholder of the Company (except as a result of sales, pledges, margin sales and similar transactions by such Purchaser to or with any current stockholder), solely as a result of such Purchaser’s acquisition of
the Notes, Note Shares, Warrant or Warrant Shares 

  

 11 

 
under this Agreement, the Company will reimburse such Purchaser and the Placement Agent for its reasonable legal and other expenses (including the cost of
any investigation preparation and travel in connection therewith) incurred in connection therewith, as such expenses are incurred. The reimbursement obligations of the Company under this paragraph shall be in addition to any liability which the
Company may otherwise have, shall extend upon the same terms and conditions to any Affiliates of the Purchasers or the Placement Agent who are actually named in such action, proceeding or investigation, and partners, directors, agents, employees and
controlling persons (if any), as the case may be, of the Purchasers, the Placement Agent and any of their Affiliates, and shall be binding upon and inure to the benefit of any successors, assigns, heirs and personal representatives of the Company,
the Purchasers, the Placement Agent and any of their Affiliates and any such Person. The Company also agrees that the Purchasers, the Placement Agent and their Affiliates, partners, directors, agents, employees or controlling persons shall have no
liability to the Company or any Person asserting claims on behalf of or in right of the Company solely as a result of the Purchasers acquiring the Notes, Note Shares, Warrant or Warrant Shares under this Agreement. 
 4.4. Indemnification. Subject to the provisions of this Section 4.4, the Company will indemnify and hold the Purchasers, the Placement
Agent and their directors, officers, shareholders, partners, employees and agents (each, a “Purchaser Party”) harmless from any and all losses, liabilities, obligations, claims, contingencies, damages, costs and expenses, including
all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party may suffer or incur as a result of or relating to (a) any breach of any of the representations,
warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against a Purchaser, or any of them or their respective Affiliates, by any stockholder of the Company
who is not an Affiliate of such Purchaser, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a breach of such Purchaser’s representation, warranties or covenants under the
Transaction Documents or any agreements or understandings such Purchaser may have with any such stockholder or any violations by the Purchaser of state or federal securities laws or any conduct by such Purchaser which constitutes fraud, gross
negligence, willful misconduct or malfeasance). If any action shall be brought against any Purchaser Party in respect of which indemnity may be sought pursuant to this Agreement, such Purchaser Party shall promptly notify the Company in writing, and
the Company shall have the right to assume the defense thereof with counsel of its own choosing. Any Purchaser Party shall have the right to employ separate counsel in any such action and participate in the defense thereof, but the fees and expenses
of such counsel shall be at the expense of such Purchaser Party except to the extent that (i) the employment thereof has been specifically authorized by the Company in writing, (ii) the Company has failed after a reasonable period of time
to assume such defense and to employ counsel or (iii) in such action there is, in the reasonable opinion of such separate counsel, a material conflict on any material issue between the position of the Company and the position of such Purchaser
Party. The Company will not be liable to any Purchaser Party under this Agreement (i) for any settlement by an Purchaser Party effected without the Company’s prior written consent, which shall not be unreasonably withheld or delayed; or
(ii) to the extent, but only to the extent, that a loss, claim, damage or liability is attributable to any Purchaser Party’s breach of any of the representations, warranties, covenants or agreements made by the Purchasers in this Agreement
or in the other Transaction Documents. 
  

 12 

 4.5. Reservation of Common Stock. As of the date hereof, the Company has reserved and the Company
shall continue to reserve and keep available at all times, free of preemptive rights, a sufficient number of shares of Common Stock for the purpose of enabling the Company to issue the Note Shares and Warrant Shares pursuant to this Agreement.

 4.6. Listing of Common Stock. The Company hereby agrees to use best efforts to maintain the listing of the Common Stock on a
Principal Market, and as soon as reasonably practicable following the Closing. 
 4.7. Equal Treatment of Purchasers. No consideration
shall be offered or paid to any person to amend or consent to a waiver or modification of any provision of any of the Transaction Documents unless the same consideration is also offered to all of the parties to the Transaction Documents. For
clarification purposes, this provision constitutes a separate right granted to each Purchaser by the Company and negotiated separately by each Purchaser, and is intended to treat the Purchasers as a class and shall not in any way be construed as the
Purchasers acting in concert or as a group with respect to the purchase, disposition or voting. 
 ARTICLE V 
 MISCELLANEOUS 
 5.1. Fees and Expenses.
Except as otherwise set forth in this Agreement, each party shall pay the fees and expenses of its advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation, preparation,
execution, delivery and performance of this Agreement. The Company shall pay all stamp and other taxes and duties levied in connection with the sale of the Notes, Note Shares, Warrants and Warrant Shares. 
 5.2. Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of the
parties with respect to the subject matter hereof and supersede all prior agreements and understandings, oral or written, with respect to such matters, which the parties acknowledge have been merged into such documents, exhibits and schedules.

 5.3. Notices. Any and all notices or other communications or deliveries required or permitted to be provided hereunder shall be in
writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto prior to 6:30
p.m. (Eastern time) on a Trading Day, (b) the next Trading Day after the date of transmission, if such notice or communication is delivered via facsimile at the facsimile number set forth on the signature pages attached hereto on a day that is
not a Trading Day or later than 6:30 p.m. (Eastern time) on any Trading Day, (c) the second Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service, or (d) upon actual receipt by the party
to whom such notice is required to be given. The address for such notices and communications shall be as set forth on the signature pages attached hereto. 
  

 13 

 5.4. Amendments; Waivers. No provision of this Agreement may be waived or amended except in a
written instrument signed, in the case of an amendment, by the Company and each Purchaser or, in the case of a waiver, by the party against whom enforcement of any such waiver is sought. No waiver of any default with respect to any provision,
condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of either
party to exercise any right hereunder in any manner impair the exercise of any such right. 
 5.5. Construction. The headings herein
are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party. 
 5.6. Successors and Assigns. This
Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted assigns. The Company may not assign this Agreement or any rights or obligations hereunder without the prior written consent of each Purchaser.
Any Purchaser may assign any or all of its rights under this Agreement to any Person to whom such Purchaser assigns or transfers any Notes, Note Shares, Warrant and Warrant Shares, provided such transferee agrees in writing to be bound, with respect
to the transferred Notes and Warrant Shares, by the provisions hereof that apply to the “Purchasers”, and provided that such transferee represents and warrants that it is an “accredited investor” or “qualified institutional
buyer” as defined in Section 3.2(d). 
 5.7. No Third-Party Beneficiaries. This Agreement is intended for the benefit
of the parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except as otherwise set forth in Sections 4.3 and 4.4. 
 5.8. Governing Law. All questions concerning the construction, validity, enforcement and interpretation of the Transaction Documents shall be
governed by and construed and enforced in accordance with the internal laws of the Commonwealth of Pennsylvania, without regard to the principles of conflicts of law thereof. Each party hereby irrevocably submits to the exclusive jurisdiction of the
state and federal courts sitting in the Montgomery County for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein (including with respect to the enforcement of any of
the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is
improper or inconvenient venue for such proceeding. Each party hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof via registered or certified
mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing
contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. The parties hereby 

  

 14 

 
waive all rights to a trial by jury. If either party shall commence an action or proceeding to enforce any provisions of the Transaction Documents, then the
prevailing party in such action or proceeding shall be reimbursed by the other party for its attorneys’ fees and other costs and expenses incurred with the investigation, preparation and prosecution of such action or proceeding. 
 5.9. Survival. The representations and warranties herein shall survive the Closing and delivery of the Notes and Warrants. 
 5.10. Execution. This Agreement may be executed in two or more counterparts, all of which when taken together shall be considered one and the same
agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart. In the event that any signature is delivered by
facsimile transmission, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof.

 5.11. Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and
upon so agreeing, shall incorporate such substitute provision in this Agreement. 
 5.12. Rescission and Withdrawal Right.
Notwithstanding anything to the contrary contained in (and without limiting any similar provisions of) the Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does
not timely perform its related obligations within the periods therein provided, then such Purchaser may rescind or withdraw, in its sole discretion from time to time upon written notice to the Company, any relevant notice, demand or election in
whole or in part without prejudice to its future actions and rights. 
 5.13. Replacement. If any certificate or instrument evidencing
any Note, Note Shares, Warrant and Warrant Shares is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new
certificate or instrument, but only upon receipt of evidence reasonably satisfactory to the Company of such loss, theft or destruction and customary and reasonable indemnity, if requested. The applicants for a new certificate or instrument under
such circumstances shall also pay any reasonable third-party costs associated with the issuance of such replacement Note, Note Shares, Warrant and Warrant Shares. 
 5.14. Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages, each of the Purchasers and the Company will be entitled to specific
performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations described in the foregoing sentence and hereby agrees to waive in any
action for specific performance of any such obligation the defense that a remedy at law would be adequate. 
  

 15 

 5.15. Payment Set Aside. To the extent that the Company makes a payment or payments to any
Purchaser pursuant to any Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be
fraudulent or preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other person under any law (including, without limitation, any bankruptcy
law, state or federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such
payment had not been made or such enforcement or setoff had not occurred. 
 5.16. Independent Nature of Purchasers’ Obligations and
Rights. The obligations of each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations of any other
Purchaser under any Transaction Document. Nothing contained herein or in any Transaction Document, and no action taken by any Purchaser pursuant thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture
or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Document. Each Purchaser shall be entitled
to independently protect and enforce its rights, including without limitation, the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other Purchaser to be joined as an additional
party in any proceeding for such purpose. Each Purchaser has been represented by its own separate legal counsel in their review and negotiation of the Transaction Documents. The Company has elected to provide all Purchasers with the same terms and
Transaction Documents for the convenience of the Company and not because it was required or requested to do so by the Purchasers. 
 (Signature Page Follows) 
  

 16 

 IN WITNESS WHEREOF, the parties hereto have caused this Convertible Note Purchase Agreement to be duly
executed by their respective authorized signatories as of the date first indicated above. 
  

			
	SYNOVA HEALTHCARE GROUP, INC.
		
	By:	 	  

		 	Name:
		 	Title:

 REMAINDER OF PAGE INTENTIONALLY LEFT BLANK 
 SIGNATURE PAGES FOR PURCHASERS FOLLOW 
  

 17 

 PURCHASER SIGNATURE PAGES TO SYNOVA 
 CONVERTIBLE NOTE PURCHASE AGREEMENT 
 IN WITNESS WHEREOF, the undersigned have caused
this Convertible Note Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above. 
 Name of Investing Entity:                      
 Signature of Authorized Signatory of Investing Entity or Individual: 
 __________________________________________________________________________________________________________ 
 Name of Authorized Signatory: _________________________________________________________________________________ 
 Title of Authorized Signatory: __________________________________________________________________________________ 
 Email Address of Authorized Entity: _____________________________________________________________________________ 
 Address for Notice of Investing Entity: 
 Address for Delivery of Note and Warrant for
Investing Entity (if not same as above): 
 Same as above 
 Note Amount: 
 EIN Number: [PROVIDE THIS UNDER SEPARATE COVER] 
  

 18 

 Schedule 1.1 
 Purchasers 
  

 19 

 EXHIBIT A 
 2006 CONVERTIBLE BRIDGE NOTE 
  

 20 

 EXHIBIT B 
 WARRANT 
  

 21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00113-of-00352.parquet"}]]